Jiming
Jiming Chen, Shenzhen CN
Patent application number | Description | Published |
---|---|---|
20140141832 | UPLINK POWER CONTROL METHOD, BASE STATION AND USER EQUIPMENT - A method includes: sending, by a user equipment (UE), uplink test signaling to transceivers for serving the UE, so that the transceivers calculate receive power of the uplink test signaling by testing the uplink test signaling; receiving, by the UE, the receive power of the uplink test signaling and transmit power of a common reference signal (CRS) from the transceivers; receiving and testing, by the UE, the CRS sent by the transceivers to obtain receive power of the CRS; calculating, by the UE, uplink path losses on paths between the UE and the transceivers according to the receive power of the uplink test signaling, the transmit power of the CRS, and the receive power of the CRS; calculating, by the UE, an aggregate path loss according to the uplink path losses on paths between the UE and the transceivers; and calculating, by the UE, uplink transmit power according to the aggregate path loss. | 05-22-2014 |
Jiming Chen, Pudong Jinqiao Shanghai CN
Patent application number | Description | Published |
---|---|---|
20130281150 | ADAPTIVE POWER CONFIGURATION METHOD AND CORRESPONDING BASE STATIONS IN A HETNET - The present invention provides a novel adaptive power configuration method and corresponding base stations in a Het Net. According to the present invention, some specific subframes of a serving base station are scheduled to serve victim UEs, while the corresponding subframes of an aggressor base station can be scheduled to serve its UEs with adaptively adjusting the transmit power instead of thoroughly muting. This adaptive power configuration scheme can efficiently reduce the interference in Het Nets to guarantee the workability of victim UEs, meanwhile more capacity performance gain can be achieved with backward compatibility to legacy UEs. | 10-24-2013 |
Jiming Jiang, Thuwal SA
Patent application number | Description | Published |
---|---|---|
20150221217 | METHYLATION BIOMARKERS FOR BREAST CANCER - A traffic monitoring system and method for mapping traffic speed and density while preserving privacy. The system can include fixed stations that make up a network and mobile probes that are associated with vehicles. The system and method do not gather, store, or transmit any unique or identifying information, and thereby preserves the privacy of members of traffic. The system and method provide real-time traffic density and speed mapping. The system and method can further be integrated with a complementary flood monitoring system and method. | 08-06-2015 |
Jiming Lin, Beijing CN
Patent application number | Description | Published |
---|---|---|
20120212862 | METHOD AND DEVICE FOR LIMITING SECONDARY ARC CURRENT OF EXTRA-HIGH VOLTAGE/ULTRA-HIGH VOLTAGE DOUBLE CIRCUIT LINES ON THE SAME TOWER - A method and a device for limiting secondary arc current of an extra-high voltage/ultra-high voltage double circuit line on the same tower. The method comprises the following steps: determining the type of a single-phase-to-ground fault when the extra-high voltage/ultra-high voltage double circuit line on the same tower has a single-phase-to-ground fault (S | 08-23-2012 |
Jiming Sun, Shanghai CN
Patent application number | Description | Published |
---|---|---|
20160053473 | FOOD WASTE DISPOSER SYSTEM AND STOPPER FOR FOOD WASTE DISPOSER SYSTEM - A food waste disposer system has a food waste disposer and a rechargeable power source that provides power to a motor of the food waste disposer. In an aspect, the motor is a permanent magnet DC motor having a nominal no-load speed in the range of 15,000 revolutions per minute to 30,000 revolutions per minute and the motor section includes a gear reduction mechanism. In an aspect, the food waste disposer system includes a power module that communicates wirelessly with a wireless activator. In an aspect, a stopper receivable in an inlet of the food waste disposer includes or is couplable to a power source which in an aspect is a rechargeable power source and in an aspect, is disposed in a housing of the stopper. In an aspect, the stopper includes a cord for coupling the stopper to the power source which is a source of AC power. | 02-25-2016 |
Jiming Zhang, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20130317360 | TARGETED DELIVERY OF ACTIVE AGENTS USING THERMALLY STIMULATED LARGE INCREASE OF PERFUSION BY HIGH INTENSITY FOCUSED ULTRASOUND - In some embodiments, the present disclosure pertains to a method of delivery of an active agent to a target tissue, in a subject in need thereof comprising positioning a high intensity focused ultrasound transducer to enable delivery of ultrasound energy to the target tissue. Such a method comprises energizing the high intensity focused ultrasound transducer; imaging at least a portion of the target tissue; and discontinuing delivery of ultrasound energy. Further, such a method may comprise administering the active agent to the subject under the conditions of thermal stimulation. In another embodiment, the present disclosure relates to a method of treating a tumor in a subject in need thereof comprising administering a therapeutic agent to the subject and providing thermal stimulation to the tumor. In some embodiments, there is provided a method for increasing the efficacy of a therapeutic agent in a target tissue. | 11-28-2013 |
Jiming Zhang, Shanghai CN
Patent application number | Description | Published |
---|---|---|
20160136265 | PHARMACEUTICAL COMPOSITION FOR VIRAL IMMUNOTHERAPY AND USES THEREOF - The present disclosure relates to a method of overcoming host immune tolerance in a subject having chronic hepatitis B virus (HBV) infection, comprising administering to the subject an immunomodulatory agent and a recombinant HBV vaccine, such that the immune tolerance of the chronic HBV infection in the subject is overcome. Moreover, the present disclosure relates to a method of treating chronic HBV infection in a subject in need thereof, comprising administering to the subject a first anti-viral agent, an immunomodulatory agent and a recombinant hepatitis B vaccine, such that the HBV infection in the subject is treated. | 05-19-2016 |